New Key Statistics Module, Z-Score and F-Score
XPAR:MLBIO Key Ratios
Market Cap € M | 13.92 |
Enterprise Value € M | 20.12 |
P/E(ttm) | 33.33 |
PE Ratio without NRI | 37.50 |
Forward PE Ratio | -- |
Price/Book | 2.02 |
Price/Sales | 1.93 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) € M | 7.00 |
EPS (TTM) € | 0.16 |
Beneish M-Score | -3.46 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 3.00 |
EV-to-EBIT | 29.99 |
EV-to-EBITDA | 20.83 |
PEG | -- |
Shares Outstanding M | 2.58 |
Net Margin (%) | 5.79 |
Operating Margin % | 8.20 |
Pre-tax Margin (%) | 6.85 |
Quick Ratio | 0.18 |
Current Ratio | 1.42 |
ROA % (ttm) | 2.81 |
ROE % (ttm) | 6.17 |
ROIC % (ttm) | 3.51 |
Dividend Yield % | -- |
Altman Z-Score | 1.62 |
XPAR:MLBIO Number of Guru Trades
XPAR:MLBIO Volume of Guru Trades
Gurus Latest Trades with XPAR:MLBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XPAR:MLBIO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data